N
Google TrendMICHAEL OLISE (500+) — Transfer Rumors: Liverpool Handed Olise Boost; Man Utd Battle Real Madrid for McTominay
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:michael olise500+bank of america fine1000+club brugge200+rb leipzig200+anthony gordon500+mid atlantic ridge earthquakes500+montez sweat2000+rob lowe1000+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Locus Biosciences Enters" (10 stories)

Top Headline Story

Locus Biosciences Enters Research Collaboration to Develop Precision Antibacterial Therapies for Ophthalmic Infections
Lead StoryBusiness Wirescience
Oct 28, 2025

Locus Biosciences Enters Research Collaboration to Develop Precision Antibacterial Therapies for Ophthalmic Infections

<a href="https://news.google.com/rss/articles/CBMihgJBVV95cUxNcURDTE1XaVJyNlVYblRaeFY4TFBmdWhvaVFrV2ZzYTRvdGNBaEtrX19iTlp0RE5mWnZocVR0bklSV2RVdkhNdDBiaEdmYWhHb01LQ1RidTJCNzV1MDNyM2ZRbXlZX0hIZmlUczNVRXhmWjR1YWk3ZUF4X2xURTBJSTNHOU9Uc282MmNPSkppZElXN3dJRGNVZjFoQldfX2d1cHBrTnhRX09rR01OemE3cGE3NTdva2J6UGJ3Y0xGQ3lfMzljanB5RTdYcjJIa3RnUzNTUzEydURpdU93bHRZWW8tQjZwLW1jekNWREZ3S1NvXzBCUHJIY3U1MmkyUXhrU2N6S3h3?oc=5" target="_blank">Locus Biosciences Enters Research Collaboration to Develop Precision Antibacterial Therapies for Ophthalmic Infections</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
500+16m ago

michael olise

Transfer Rumors: Liverpool Handed Olise Boost; Man Utd Battle Real Madrid for McTominay

Filter stories
1000+16m ago

bank of america fine

Bank of America fined $1.2 billion over money-laundering violations

Filter stories
200+16m ago

club brugge

LIVE: Dan toch 1-1! Club laat zich na penalty Tresoldi te makkelijk vangen, Lautaro zorgt voor gelijkmaker

Filter stories
200+16m ago

rb leipzig

Nach 6:0 in der Liga: Demichelis erwartet anderes Kaliber

Filter stories

Search Results for "Locus Biosciences Enters"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

9 stories displayed
Locus Biosciences Awarded $3.3 Million from NIH to Support Clinical Trial of AI-Designed Bacteriophage Therapy for Pneumonia caused by Antibiotic Resistant Bacteria
Business Wiretech

Locus Biosciences Awarded $3.3 Million from NIH to Support Clinical Trial of AI-Designed Bacteriophage Therapy for Pneumonia caused by Antibiotic Resistant Bacteria

<a href="https://news.google.com/rss/articles/CBMixgJBVV95cUxOQ0RsTVMwME1la1E1OXM1b0xVS1QxbnhpWllBUWZTWHFCcC1URkpMYVNLcVBCQUpJc0VSVGc0UWZPQVBfaHVvbVQwcm5FdXg0RzhGLVpLRVhPVnhQMGVFb2VzNXlRa2ZrTWI2SFBreDFrTzVkOUhPcS00QTdfVTFPN0NsRXRkcXdjZW5ac0RBS0U1dzk1ejJfRjUyNS1QLUNOTGJiUTRDcUNpX2lXR1hxUFVkYUtkcHp6ZDJJYUZ6bDNwdmJaTHJRNVpDalM0VFphWnZxUm9RU2NxTmhka0RLS0xab3JXWWE4NnVtcWx0djRSTThYN0hEcFZPdHQ0ekZTRGZCQnRZTTFjSnJHM09XVklSaWtIMjZKVHhlRFFNVWRoRlRGaUpxbXlKdzF5Mm9VZVVnYXktdHhjRHYtbUJzREVpWFcxdw?oc=5" target="_blank">Locus Biosciences Awarded $3.3 Million from NIH to Support Clinical Trial of AI-Designed Bacteriophage Therapy for Pneumonia caused by Antibiotic Resistant Bacteria</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
Locus Biosciences Enters a Collaboration and License Agreement with Johnson & Johnson Innovation to develop CRISPR-Cas3 Bacteriophage Therapeutics
PR Newswirescience

Locus Biosciences Enters a Collaboration and License Agreement with Johnson & Johnson Innovation to develop CRISPR-Cas3 Bacteriophage Therapeutics

<a href="https://news.google.com/rss/articles/CBMiqAJBVV95cUxOZW53VWFzVVlHeWtQcHNONFZBLVFCcS16THMwUXg4eU1PZkFwWWFvVnNfQXdGSjNNcXdnMUY2d1NEbW9QczF1SGVDUmtfLXktQlBkX3dlY1U2YmtYcGlkX1NScXVtOF9mTUppOGx2SzZZa1FGY2lpWEVER01RWDljTVZPTzRDaWVHWnF4YkdRWXNyWjNiNk1OeXNJbkhUbHRadDU1UTZZU1hISkRudEkteW14bHc2VG12UU50amFVT3NPWUJaelIyamUyQ1BUdzk3YV8yR2FRMjZDR3FzTEtLOG93VnZTaGI1V2hKci1hRnlzdEVlSHFhV2gybFgtNjFxNHFuSWNjZXczaWtoVDg1NnVXQ0xrRVdKdGtOYjVNVnFQa3NTVFNqeQ?oc=5" target="_blank">Locus Biosciences Enters a Collaboration and License Agreement with Johnson & Johnson Innovation to develop CRISPR-Cas3 Bacteriophage Therapeutics</a>  <font color="#6f6f6f">PR Newswire</font>

Read Full StoryMore like this
Paul Garofolo, Locus Biosciences
Investment Reportsscience

Paul Garofolo, Locus Biosciences

<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxPdTZydnNUZ0dqZ0xGWVhLWnZiSEdncmFvZi11RlVRNmJHVDZVY2NqNWhkZXl4Qlc0WG5Mel9FRG9pVktNNWQ0OTAzTXRGeG5feDhhU0ozRG1YQnlWVXotV2hrSUNpZzZGV01tUmhfbDlOTjNlZk9aTS01UndScV9ydVp5MFV1dkNFMk9Pd2JFampJcjRScXBhdjJBYWg5eTQ?oc=5" target="_blank">Paul Garofolo, Locus Biosciences</a>  <font color="#6f6f6f">Investment Reports</font>

Read Full StoryMore like this
Phage Therapy’s Neglected Potential Is Finally Being Realized
Genetic Engineering and Biotechnology Newsgeneral

Phage Therapy’s Neglected Potential Is Finally Being Realized

<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxQb0Jzb1QtNFRseGFZUnd2Yl9uZjlyZHNpM25NaTgtTkN5M1JKTllxRDFEeFpWQTQ1cU1Lek5GMVhSYWFhWG5kRkpOZDBORW84blZwWnBuYURnSkpFcjRFSXAxcFB0WE9XMEg5Y1FUeHdxN0I0cDNjT0lDMFFBMldIbTNkcTE1WmN1TjRteDExcFc3NWQ3c2c3WU9YaEpLM3E4dXBFREhLX0prU2I2Tzh4eU12WjJQb0RjRWc?oc=5" target="_blank">Phage Therapy’s Neglected Potential Is Finally Being Realized</a>  <font color="#6f6f6f">Genetic Engineering and Biotechnology News</font>

Read Full StoryMore like this
Morrisville biotech gains 'buying power' with $35M raise
The Business Journalstech

Morrisville biotech gains 'buying power' with $35M raise

<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxQa19xZ3JSOU9PV0NRUm9odm9KMmdtS2VPaEE4ZU5MTGZsd0FLbVdlcHhpVGlIbVY5SnB1bXRCWW1vQUZHMWlHRGt2SnF3OHU2bUJmYWY2ZVh2MTdDNlcwUDZncVBGMTdua1FWVEN1c3IxcHZLNk1Qdm1wY3FvUGNHeDFWMnk2bHVDNjRVZW5QNmp3Z24ybUt4MU42T3RLSzg3cGtNU05XZTh4Z1dU?oc=5" target="_blank">Morrisville biotech gains 'buying power' with $35M raise</a>  <font color="#6f6f6f">The Business Journals</font>

Read Full StoryMore like this
Locus raises $19M to take CRISPR-based antimicrobial ‘Pac-Man’ into clinic
Fierce Biotechtech

Locus raises $19M to take CRISPR-based antimicrobial ‘Pac-Man’ into clinic

<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxQWXVvQldrMlhOQnVNaTFJN3hOOGRqTTJMSm1ZNDVEMDRrXzNUT1U2V3FxdmhocTFabjNSc0pYZXlaU1NCM3hoQURZRXZrVW8ybGxuNDRVZ04zSEFuOEJQelBqMElFMmdncXdhRkN2WXc3NzJZa3k3NVNldHpWQ0YzX0p0THF5UDkybU96SXkta2VnSGRxcFA1Nk5WV2dKdWRTVVhIV2tSemJMVVV2eUE?oc=5" target="_blank">Locus raises $19M to take CRISPR-based antimicrobial ‘Pac-Man’ into clinic</a>  <font color="#6f6f6f">Fierce Biotech</font>

Read Full StoryMore like this
Paul Garofolo, Locus Biosciences
Investment Reportsscience

Paul Garofolo, Locus Biosciences

<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE1lbnNBLVpuajBZamFvZllqczYzQVdvM25MZW93X1p1UHI1NmJZZHAwNkFLR0NWemFvYnEwRjBwTUNyR0JRRlduR2tkUXBvSk9ET1VoZ0g1QWtjNnk4ekkzVTRsOHpiT09ndE1GNVNB?oc=5" target="_blank">Paul Garofolo, Locus Biosciences</a>  <font color="#6f6f6f">Investment Reports</font>

Read Full StoryMore like this
Leurent joins AbbVie Ventures
Global Venturinggeneral

Leurent joins AbbVie Ventures

<a href="https://news.google.com/rss/articles/CBMigAFBVV95cUxQWmF4SHFJYzlaS1JmejkwcDVuUWpRMXlvblp0TkktY2RLQ1lLcXFtdUlKOUYyQ3dvWmp2cmZWaWUwaE0taDVfdnlnbEhJQ1NMaFhFSXd4WW1WVzFDS2VHUjBNYTZEUC0yQm5WZ2xNWXRXLW9peGFLS2c1SzduRVpHRw?oc=5" target="_blank">Leurent joins AbbVie Ventures</a>  <font color="#6f6f6f">Global Venturing</font>

Read Full StoryMore like this
Complicated Urinary Tract Infections Market Set for Expansion by 2036, Supported by Recent Drug Approvals Including GSK/Spero Therapeutics’ UTEBZI and Wockhardt’s ZAYNICH and Emerging Therapies | DelveInsight
Business Upturnmarkets

Complicated Urinary Tract Infections Market Set for Expansion by 2036, Supported by Recent Drug Approvals Including GSK/Spero Therapeutics’ UTEBZI and Wockhardt’s ZAYNICH and Emerging Therapies | DelveInsight

<a href="https://news.google.com/rss/articles/CBMi2wJBVV95cUxNRFhvd2drQlFZXzJDejltY3NrQ2pSd0tGb0tnTEQ0c2Q4ZENYZWZyMW1uMml4YnZSTEtRNm9ScHY2VHNXcUVJbk5WaGcxNnBjaVE0WEtETUVYMk05QWxacVYtcm9PczBQQ0NsUGtrTEpGYWtybi00bzFubWg4am9ncHZza1lGWkdLSEZScHQ5TnVlSlJ3eVA5cVYzTzNzOXVqaFd6RXFESWJYZVllMDlHMGJSOHVRWkI3OTE1VE9UOXZ5Qk53M1VrWGlXOVpNcTNtTzZQWXU3anBTWk93TExMMjNURFRlYXZrQ09mdXJuMkVwcmV5SVdlbUk1QXZnOXlCTmlVekpGVTRfTHJLY05Pell5eS1CbGhuZS1RcXNMSGdMN1VHMHoyb09yMGJ4cUZFWHEwS2xFM1U2LVdSLXNmb1VHZk5rUkFsWjFZb3c4Z05XMV9nSXlmV1dpVQ?oc=5" target="_blank">Complicated Urinary Tract Infections Market Set for Expansion by 2036, Supported by Recent Drug Approvals Including GSK/Spero Therapeutics’ UTEBZI and Wockhardt’s ZAYNICH and Emerging Therapies | DelveInsight</a>  <font color="#6f6f6f">Business Upturn</font>

Read Full StoryMore like this
"Locus Biosciences Enters" — Live Google News Trends & Headlines